35833-70-6

Basic information

• Product Name: Cabraleahydroxylactone acetate
• Synonyms: Cabraleahydroxylactone acetate;Cabralea-hydroxylactone-3alpha-acetate
• CAS NO: 35833-70-6
• Molecular Formula: C29H46O4
• Molecular Weight: 458.67
• Mol File: 35833-70-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 529.9±23.0 °C(Predicted)
• Appearance: /
• Density: 1.09±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Cabraleahydroxylactone acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Cabraleahydroxylactone acetate(35833-70-6)
• EPA Substance Registry System: Cabraleahydroxylactone acetate(35833-70-6)

Safety Data

• Hazardous Substances Data: 35833-70-6(Hazardous Substances Data)

Usage

General Description

"Cabraleahydroxylactone acetate" is a rare and complex chemical compound. It is not commonly featured in general databases or mentioned in usual scientific literature, which suggests that it could be a novel chemical entity or possibly a derivative or specific form of another known compound. Due to limited information, its properties, uses, or biological activities are unknown. More research or context would be necessary to detail its structures, properties, and potential applications.

Upstream product

• 124580-50-3 3β-acetoxy-20β_FH-dammaran-20-ol 
• 19865-91-9 17-[(5α-methyl)-3,4H-furane-2-one]-25,26,27-trisnor-dammar-3-one 
• 108-24-7 acetic anhydride 
• 471-69-2 dipterocarpol 

Relevant articles and documents

Newly synthesised oxime and lactone derivatives from: Dipterocarpus alatus dipterocarpol as anti-diabetic inhibitors: Experimental bioassay-based evidence and theoretical computation-based prediction

Dipterocarpus alatus-derived products are expected to exhibit anti-diabetes properties. Natural dipterocarpol (1) was isolated from Dipterocarpus alatus collected in Quang Nam province, Vietnam; afterwards, 20 derivatives including 13 oxime esters (2 and 3a-3m) and 7 lactones (4, 5, 6a-6e) were semi-synthesised. Their inhibitory effects towards diabetes-related proteins were investigated experimentally (α-glucosidase) and computationally (3W37, 3AJ7, and PTP1B). Except for compound 2, the other 19 compounds (3a-3m, 4, 5, and 6a-6d) are reported for the first time, which were modified at positions C-3, C-24 and C-25 of the dipterocarpol via imidation, esterification, oxidative cleavage and lactonisation reactions. A framework based on docking-QSARIS combination was proposed to predict the inhibitory behaviour of the ligand-protein complexes. Enzyme assays revealed the most effective α-glucosidase inhibitors, which follow the order 5 (IC50 of 2.73 ± 0.05 μM) > 6c (IC50 of 4.62 ± 0.12 μM) > 6e (IC50 of 7.31 ± 0.11 μM), and the computation-based analysis confirmed this, i.e., 5 (mass: 416.2 aμ polarisability: 52.4 ?3; DS: -14.9 kcal mol-1) > 6c (mass: 490.1 aμ polarisability: 48.8 ?3; DS: -13.7 kcal mol-1) > 6e (mass: 549.2 aμ polarisability: 51.6 ?3; DS: -15.2 kcal mol-1). Further theoretical justifications predicted 5 and 6c as versatile anti-diabetic inhibitors. The experimental results encourage next stages for the development of anti-diabetic drugs and the computational strategy invites more relevant work for validation. This journal is